Mark is Co-founder/Editor of TechBuzz News. From Ogden, UT, Mark attended WSU, BYU, and Tufts. He has been involved in tech, media, publishing since the 80s.
Mayer Brown announced today that Spencer Glende has joined the firm's Salt Lake City office as a partner and a member of the firm's Technology & IP Transactions practice and Emerging Companies & Venture Capital (EC & VC) practice.
Spencer has extensive experience structuring and negotiating
University of Utah President Taylor Randall announced today the launch of a yet another entrepreneur initiative designed to boost student entrepreneurial activity and bolster Utah’s already enviable reputation for entrepreneurship and financial technology innovation and education.
In partnership with the Stena Foundation whose founders are Steve and Jana Smith,
University of Utah President Taylor Randall announced today the launch of a yet another entrepreneur initiative designed to boost student entrepreneurial activity and bolster Utah’s already enviable reputation for entrepreneurship and financial technology innovation and education.
In partnership with the Stena Foundation whose founders are Steve and Jana Smith,
Facta, Inc., a SaaS financial technology company co-headquartered in San Francisco and Salt Lake City, has announced it has raised a $4 million of seed round. Inner Loop Capital, Point Field Partners, and a group of individual investors participated in the round. This capital will enable Facta to further
Facta, Inc., a SaaS financial technology company co-headquartered in San Francisco and Salt Lake City, has announced it has raised a $4 million of seed round. Inner Loop Capital, Point Field Partners, and a group of individual investors participated in the round. This capital will enable Facta to further
DiscGenics, Inc. today announced the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to the company's Injectable Disc Cell Therapy (IDCT or rebonuputemcel), an injectable, allogeneic discogenic progenitor cell therapy for the treatment of symptomatic lumbar degenerative disc disease (DDD).
"
DiscGenics, Inc. today announced the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to the company's Injectable Disc Cell Therapy (IDCT or rebonuputemcel), an injectable, allogeneic discogenic progenitor cell therapy for the treatment of symptomatic lumbar degenerative disc disease (DDD).
"
EPIC Ventures (Salt Lake City) announced today that it has promoted Jack Boren to Managing Partner and Riley Jarman to Associate. As a Managing Partner, Jack Boren joins Co-Founders and Managing Partners Kent Madsen and Nick Efstratis to oversee the Firm’s overall strategy and operations.
Jack joined EPIC
